CAS 82626-01-5
:Alpidem
Description:
Alpidem, with the CAS number 82626-01-5, is a chemical compound that belongs to the class of drugs known as anxiolytics or sedatives. It is primarily characterized by its ability to modulate the GABA (gamma-aminobutyric acid) receptor, which plays a crucial role in inhibitory neurotransmission in the central nervous system. Alpidem is known for its anxiolytic properties, making it useful in the treatment of anxiety disorders. The compound exhibits a relatively rapid onset of action and a favorable pharmacokinetic profile, which includes a moderate half-life. Its chemical structure features a unique arrangement of functional groups that contribute to its biological activity. While it has shown promise in clinical settings, the use of Alpidem has been limited due to concerns regarding side effects and dependency potential, similar to other benzodiazepine-like medications. As with any pharmaceutical agent, it is essential to consider the therapeutic benefits against potential risks when evaluating its use in clinical practice.
Formula:C21H23Cl2N3O
InChI:InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3
InChI key:InChIKey=JRTIDHTUMYMPRU-UHFFFAOYSA-N
SMILES:C(C(N(CCC)CCC)=O)C1=C(N=C2N1C=C(Cl)C=C2)C3=CC=C(Cl)C=C3
Synonyms:- 2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide
- 6-Chlor-2-(4-chlorphenyl)-N,N-dipropylimidazol(1,2-a)pyridin-3-acetamid
- 6-Chloro-2-(4-chlorophenyl)-N,N-dipropylimidazo[1,2-a]pyridine-3-acetamide
- 6-Chloro-2-(p-chlorophenyl)-N,N-dipropylimidazo(1,2-a)pyridine-3-acetamide
- Alpidem [USAN:INN:BAN]
- Alpidemum
- Alpidemum [Latin]
- Ananxyl
- Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-N,N-dipropyl-
- Sl 80.0342-00
- Unii-I93Sc245Qz
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Alpidem
CAS:Controlled Product<p>Applications A peripheral benzodiazepine GABAA receptor ligand, a new anxiolytic.<br>References Min, D., et al.: Pharmacotherapy, 12, 68 (1992), Rothwell, C., et al.: J. Toxicol. Sci., 27, 35 (2002), Gonzalez-Diaz, H., et al.: Bioorg. Med. Chem. Lett., 15, 1651 (2005), Boelsterli, U., et al.: Curr. Drug Metab., 7, 715 (2006), Rietjens, I., et al.: Chem. Res. Toxicol., 19, 977 (2006),<br></p>Formula:C21H23Cl2N3OColor and Shape:NeatMolecular weight:404.33Alpidem
CAS:Controlled Product<p>Alpidem is a low-potency short-acting benzodiazepine that is used as a sedative or hypnotic. It is also used for the treatment of insomnia, anxiety disorders, and panic disorder. Alpidem has significant interactions with other drugs such as triazolam, lorazepam and clozapine. It binds to the α1 subunit of the GABAA receptor and increases the activity of gamma-aminobutyric acid (GABA) in the brain by increasing its synthesis and inhibiting its degradation. Alpidem also has been shown to have some anxiolytic effects in animal models.</p>Formula:C21H23Cl2N3OPurity:Min. 95%Color and Shape:White To Tan SolidMolecular weight:404.33 g/molAlpidem
CAS:<p>Alpidem (Ananxyl), a non-sedative imidazopyridine anxiolytic, treats anxiety with high benzodiazepine receptor affinity.</p>Formula:C21H23Cl2N3OPurity:99.56% - 99.97%Color and Shape:White To Off-White SolidMolecular weight:404.33




